Paper25220102
Recurrent vulvovaginitis.
Powell AM and 1 other. Best Pract Res Clin Obstet Gynaecol, 2014. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Recurrent vulvovaginitis. Papers, record 25220102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25220102
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vulvovaginitis | Major topic |
| Candidiasis, Vulvovaginal | |
| Female | |
| Humans | |
| Recurrence | |
| Trichomonas Vaginitis | |
| Vaginosis, Bacterial |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42051707 | The interventional value and research progress of vaginal microbiota transplantation in improving female sexual quality of life associated with dysbiosis of the reproductive microecosystem. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42051707 | PubMed |
| 41024984 | Discovering a new paradigm: Gut microbiota as a central modulator of sexual health. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/41024984 | PubMed |
| 40478268 | Importance of advancing antifungal treatments: a focus on chitinases and glucanases in Candida therapy. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/40478268 | PubMed |
| 40297512 | In vitro co-culture model of Trichomonas vaginalis, Candida albicans, and Lactobacillus crispatus: a system for assessing antimicrobial activity and microorganism interactions in vaginitis. | Front Parasitol | 2025 | https://conductscience.org/library/papers/40297512 | PubMed |
| 40136919 | Improving Vaginal Health with a Zinc-Containing Vaginal Hydrogel. | Gels | 2025 | https://conductscience.org/library/papers/40136919 | PubMed |
| 40084887 | Mycobiome: an underexplored kingdom in cancer. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/40084887 | PubMed |
| 39611300 | Healthcare utilization and costs following molecular diagnostic testing among patients with vaginitis. | J Comp Eff Res | 2025 | https://conductscience.org/library/papers/39611300 | PubMed |
| 39273118 | Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273118 | PubMed |
| 38004053 | Efficacy of a Novel Rigenase® and Polyhexanide (Fitostimoline® Septagel) Hydrogel Device for the Treatment of Vulvovaginitis Symptoms: Cross-Sectional Analysis of a National Survey and Prospective Observational Study. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/38004053 | PubMed |
| 37374096 | The Female Reproductive Tract Microbiota: Friends and Foe. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37374096 | PubMed |
| 36950702 | Experience With a Non-Hormonal Centella Asiatica, Hyaluronic Acid and Prebiotic-Based Vaginal Gel in Women With Recurrent Vulvovaginal Candidiasis: Case Studies. | Clin Med Insights Case Rep | 2023 | https://conductscience.org/library/papers/36950702 | PubMed |
| 35528623 | High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran. | Curr Med Mycol | 2021 | https://conductscience.org/library/papers/35528623 | PubMed |
| 34575468 | Antimicrobial Polymer-Based Hydrogels for the Intravaginal Therapies-Engineering Considerations. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575468 | PubMed |
| 34445090 | Star-Shaped Poly(furfuryl glycidyl ether)-Block-Poly(glyceryl glycerol ether) as an Efficient Agent for the Enhancement of Nifuratel Solubility and for the Formation of Injectable and Self-Healable Hydrogel Platforms for the Gynaecological Therapies. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445090 | PubMed |
| 33983051 | Real-world effectiveness and tolerability of Zelesse cream® for treating vulvovaginitis in adult women: an observational, prospective study. | J Int Med Res | 2021 | https://conductscience.org/library/papers/33983051 | PubMed |
| 32997581 | Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness. | Popul Health Manag | 2020 | https://conductscience.org/library/papers/32997581 | PubMed |
| 32269261 | A meta-analysis of mannose-binding lectin gene polymorphisms with the risk of recurrent vulvovaginal infections. | Sci Rep | 2020 | https://conductscience.org/library/papers/32269261 | PubMed |
| 31992328 | Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. | Ann Clin Microbiol Antimicrob | 2020 | https://conductscience.org/library/papers/31992328 | PubMed |
| 31555269 | Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions. | Front Immunol | 2019 | https://conductscience.org/library/papers/31555269 | PubMed |
| 30564664 | Is uncertain vulvovaginal candidiasis a marker of vulvodynia? A study in a Dutch general practice research database. | BJGP Open | 2017 | https://conductscience.org/library/papers/30564664 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25220102
GET https://conductscience.org/api/papers/v1/25220102/cited_by?page=2